U.S. Hospitality Stock News

NYSE:PRU
NYSE:PRUInsurance

Prudential Financial (PRU) Margin Improvement Challenges Longstanding Earnings Skepticism In Latest Results

Prudential Financial (PRU) opened 2026 with Q1 revenue of US$14.3b and basic EPS of US$1.69 on net income of US$588m, setting a clear marker for how the year is starting to shape up. Over recent quarters, the company has seen revenue move from US$13.5b and EPS of US$1.97 in Q1 2025 to US$16.2b and EPS of US$2.56 in Q4 2025, with trailing twelve month EPS at US$9.78 on net income of US$3.4b across US$62.6b of revenue. For investors, the key question now is how these earnings and a 5.5%...
NasdaqGS:STBA
NasdaqGS:STBABanks

A Look At S&T Bancorp (STBA) Valuation After Recent Share Price Moves

Context for S&T Bancorp stock S&T Bancorp (STBA) has drawn investor attention after recent share price moves, with the stock last closing at $44.54 and showing mixed short term returns over the past week, month, and past 3 months. See our latest analysis for S&T Bancorp. For context, S&T Bancorp’s recent 1-month share price return of 3.68% and year to date share price return of 13.51% sit alongside a 1-year total shareholder return of 24.33%, suggesting momentum that has been building rather...
NYSE:BFAM
NYSE:BFAMConsumer Services

Bright Horizons Q1 EPS Holds Firm As Margin Story Supports Bullish Narratives

Bright Horizons Family Solutions (BFAM) has opened 2026 with Q1 results showing revenue of US$712.2 million and basic EPS of US$0.63, alongside trailing twelve month revenue of US$3.0 billion and EPS of US$3.37. Over the past year, quarterly revenue has ranged from US$665.5 million to US$802.8 million, while EPS has moved between US$0.39 and US$1.38. This provides a clear view of how the top and bottom lines have tracked into the latest print. With trailing net profit margin at 6.3%,...
NYSE:AES
NYSE:AESRenewable Energy

AES (AES) Q1 EPS Jump Challenges Bearish Views On Profitability Sustainability

AES (AES) opened 2026 with Q1 revenue of US$3.2b and basic EPS of US$0.68, setting the tone for how investors will read the latest numbers against its recent track record. The company has seen quarterly revenue move from US$2.9b in Q1 2025 to US$3.2b in Q1 2026, while basic EPS shifted from US$0.06 to US$0.68 over the same period, against a trailing twelve month EPS of US$1.94. With a trailing net profit margin of 11.1%, slightly above last year, this set of results lands in a context of...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

TransMedics Group (TMDX) Q1 EPS Lull Tests Bullish Profitability Narratives

Q1 2026 earnings snapshot TransMedics Group (TMDX) has just posted Q1 2026 results with revenue of US$173.9 million, basic EPS of US$0.21 and net income of US$7.3 million, set against a current share price of US$72.92. The company has reported revenue of US$121.6 million in Q4 2024 and US$173.9 million in Q1 2026, while quarterly basic EPS moved from US$0.20 to US$0.21 over the same span. With trailing earnings growth and a higher net profit margin in the background, this quarter’s numbers...
NYSE:TIC
NYSE:TICProfessional Services

Why TIC Solutions (TIC) Is Up 14.3% After Record NV5-Driven Q1 Sales But Wider Loss

TIC Solutions, Inc. reported first-quarter 2026 results, with sales rising to US$488.03 million from US$234.22 million a year earlier, while net loss widened to US$41.55 million. The quarter highlighted the impact of the NV5 Global acquisition, as record revenue and reaffirmed 2026 guidance contrasted with continued losses and higher financing costs. We’ll now examine how the record NV5-driven revenue and reaffirmed 2026 outlook reshape TIC Solutions’ longer-term investment narrative. The...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

What Pulse Biosciences (PLSE)'s Mixed Q1 Results and nPulse AF Data Reveal for Shareholders

Pulse Biosciences recently reported first-quarter 2026 results showing a wider net loss of US$18.58 million and basic loss per share of US$0.27, while also missing consensus revenue expectations with about US$0.4 million in sales. At the same time, the company released late-breaking, positive first-in-human data for its nPulse Cardiac Catheter System in atrial fibrillation, reinforcing confidence in its non-thermal nsPFA platform with high procedural success, durable rhythm control and a low...
NYSE:CVS
NYSE:CVSHealthcare

CVS Health (CVS) Q1 2026 Margin Compression And One Off Loss Test Bullish Narratives

CVS Health (CVS) opened 2026 with Q1 revenue of about US$100.4 billion and basic EPS of US$2.31, setting the tone for this reporting season. The company has seen quarterly revenue move from US$94.1 billion in Q1 2025 to US$100.4 billion in Q1 2026, while basic EPS over the same quarters shifted from US$1.41 to US$2.31, and trailing twelve month EPS now sits at roughly US$2.31 on revenue of US$405.7 billion. With reported net margins over the last year sitting at 0.7% and influenced by a large...
NYSE:LEVI
NYSE:LEVILuxury

Is It Too Late To Consider Levi Strauss (LEVI) After Its 1 Year 42.8% Rally?

If you are wondering whether Levi Strauss stock still offers value after its recent run, or if you may be late to the party, this article breaks down what the current price might be implying about the company. With the share price at US$23.03 and returns of 5.2% over 7 days, 17.2% over 30 days, 10.6% year to date and 42.8% over 1 year, many investors are questioning what is already priced in. Those moves sit alongside a longer record, with returns of 83.4% over 3 years but a 4.9% decline...
NYSE:NEXA
NYSE:NEXAMetals and Mining

Nexa Resources (NEXA) Is Up 18.1% After Cerro Lindo Stream Step-Down Boosts Earnings Flexibility – Has The Bull Case Changed?

Nexa Resources has already reported a strong first quarter of 2026, with net revenues rising to about US$888 million and net income reaching US$118 million on the back of higher metal prices, stronger smelting volumes, and resolved disruptions in Peru. A key shift was the Cerro Lindo silver streaming step-down, which cut the streamed share from 65% to 25% after a delivery threshold, allowing Nexa to retain and sell an additional 1.2–1.3 million ounces of silver at spot prices from the second...
NYSE:AMC
NYSE:AMCEntertainment

AMC Entertainment (AMC) Q1 Losses Keep Pressure On Bullish Margin Expansion Narratives

AMC Entertainment Holdings (AMC) opened Q1 2026 with revenue of US$1,045.4 million and a basic EPS loss of US$0.22, compared with Q1 2025 revenue of US$862.5 million and a basic EPS loss of US$0.47 as the stock trades around US$1.64. Over the past year, revenue has ranged between US$862.5 million and US$1,397.9 million per quarter, while quarterly basic EPS losses have moved between roughly US$0.01 and US$0.58, leaving investors focused on how much of that top line is dropping through to the...
NYSE:KOS
NYSE:KOSOil and Gas

Kosmos Energy Reshapes Portfolio With Asset Sale And Capital Raises

Kosmos Energy (NYSE:KOS) reports record production in Q1 2026, linked to the GTA and Jubilee field expansions. The company announces a US$350 million bond issue and a US$200 million equity raise, with proceeds aimed at reducing debt. Kosmos agrees to sell its Equatorial Guinea assets for up to US$220 million, while also taking final investment decision on the Tiberius project. These operational and financing actions come alongside ongoing losses and amount to a broad portfolio and balance...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Newell Brands (NWL) Is Up 13.2% After Raising 2026 Sales Outlook - Has The Bull Case Changed?

In early May 2026, Newell Brands reported first-quarter results showing sales of US$1,549 million versus US$1,566 million a year earlier, with net loss narrowing to US$33 million and loss per share improving to US$0.08 from US$0.09. At the same time, the company lifted its full-year 2026 net sales outlook to a range of flat to 2% growth, suggesting management sees recent operational improvements as sustainable despite only modest recent sales movement. Now, we'll examine how Newell’s...
NasdaqGS:FANG
NasdaqGS:FANGOil and Gas

Is It Too Late To Consider Diamondback Energy (FANG) After Recent Shale Discipline Focus?

Wondering if Diamondback Energy's share price still offers value after a strong run, or if most of the opportunity is already priced in. The stock closed at US$195.08, with a 7 day return of a 5.1% decline, a 30 day return of a 0.2% decline, a 28.1% return year to date, and a 47.2% return over the last year. These figures can affect how you think about both upside potential and risk today. Recent news around US shale producers has kept attention on oil supply discipline and capital returns...
NasdaqCM:TYGO
NasdaqCM:TYGOElectrical

Tigo Energy (TYGO) Quarterly Loss Challenges Bullish Narrative Of Recent Profitability Turnaround

Tigo Energy (TYGO) opened Q1 2026 with revenue of US$25.2 million and a basic EPS loss of US$0.02, alongside net income of US$1.8 million in losses. The trailing twelve month line shows revenue of US$109.9 million and basic EPS of US$0.05 supported by net income of US$3.4 million. The company has seen quarterly revenue move from US$18.8 million in Q1 2025 to US$25.2 million in Q1 2026, with basic EPS shifting from a loss of US$0.11 to a loss of US$0.02. This positions a story where improving...
NYSE:HII
NYSE:HIIAerospace & Defense

HII Contracts Link Next Gen Naval Platforms With Apparent Valuation Discount

Huntington Ingalls Industries (NYSE:HII) has received a $283 million lead yard support contract for the U.S. Navy's FF(X) class frigate program. The company also secured a Defense Innovation Unit award to develop an autonomous launch and recovery system for submarine deployed unmanned underwater vehicles. These contracts expand HII's work in advanced surface warships and undersea autonomy for future naval operations. For investors tracking defense exposure, NYSE:HII sits at the intersection...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Madrigal Pharmaceuticals (MDGL) Quarterly Loss Of US$94 Million Tests Bullish Margin Turnaround Narrative

Madrigal Pharmaceuticals (MDGL) opened Q1 2026 with total revenue of US$311.3 million, a basic EPS loss of US$4.13, and net income loss of US$94.4 million, setting the tone for how its growth story is feeding through to the income statement. The company has seen reported quarterly revenue move from US$137.3 million in Q1 2025 to US$311.3 million in Q1 2026. Over the same period, basic EPS ranged from a loss of US$1.90 in Q2 2025 to a loss of US$5.08 in Q3 2025, so investors are watching how...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Is It Time To Reconsider Maplebear (CART) After Recent Share Price Weakness?

Considering whether Maplebear at around US$40 a share is starting to look attractive, or if the stock still carries too much risk for the price you would be paying. Over the last week the stock saw a 5.2% decline, while the 30 day return sits at a 2.3% decline and the year to date move is an 8.5% decline, leaving the 1 year return at a 6.5% decline. Recent coverage has focused on how the stock's performance over different time frames may be influencing sentiment around its long term...
NYSE:EMR
NYSE:EMRElectrical

Emerson Electric (EMR) EPS Jump Reinforces Bullish Margin Narratives In Q2 2026 Results

Emerson Electric (EMR) has just posted Q2 2026 results with revenue of US$4.6 billion, Basic EPS of US$1.10, and net income excluding extra items of US$618 million. This sets a clear marker for how the business is currently earning its money. The company has seen quarterly revenue move from US$4.4 billion in Q2 2025 to US$4.6 billion in Q2 2026, while Basic EPS shifted from US$0.86 to US$1.10 over the same period, giving you a clean year over year read on the top and bottom line. With...
NYSE:MCO
NYSE:MCOCapital Markets

Is It Too Late To Consider Moody's (MCO) After Recent Share Price Weakness?

If you are wondering whether Moody's at around US$448 per share is offering good value right now, or if the stock is already pricing in a lot of optimism, this article breaks that question down in plain terms. The stock is roughly flat over the last month with a 1.0% return. However, that sits against a 10.1% year to date decline and a 3.4% decline over the past year, following stronger 3 year and 5 year returns of 48.1% and 46.3%. Recent market attention on credit risk, debt markets and...
NasdaqGS:MLYS
NasdaqGS:MLYSBiotechs

Does Mineralys Therapeutics (MLYS) NDA Momentum and Conference Push Reveal Its Core Hypertension Strategy?

In early May 2026, Mineralys Therapeutics reported that it had submitted a New Drug Application for its aldosterone synthase inhibitor lorundrostat in treatment-resistant hypertension, scheduled its first-quarter 2026 results and earnings call for May 6, and granted inducement equity awards to new non-executive employees under its 2025 inducement plan. Alongside this regulatory progress, Mineralys is drawing increased investor and industry attention through positive commentary on...
NYSE:CRI
NYSE:CRILuxury

Carter’s (CRI) Net Margin Slide To 3% Tests Bullish Earnings Recovery Narratives

Carter's (CRI) opened 2026 with Q1 revenue of US$681.1 million and basic EPS of US$0.39 on net income of US$13.9 million, setting the tone for how the rest of the year might shape up. Over the past year, revenue has ranged from US$585.3 million to US$925.5 million per quarter, while basic EPS has moved between roughly US$0.01 and US$1.78. This gives you a clear sense of how the top and bottom lines have been tracking into this latest report. Against that backdrop of modest revenue growth...
NasdaqGS:SWKS
NasdaqGS:SWKSSemiconductor

Skyworks Solutions Q2 Margins Weaken Reinforcing Bearish Profitability Narratives

Skyworks Solutions (SWKS) opened Q2 2026 with total revenue of US$943.7 million and basic EPS of US$0.24, alongside trailing 12 month EPS of US$2.41 on revenue of US$4.0 billion. Over recent quarters, revenue moved from US$953.2 million and EPS of US$0.43 in Q2 2025 to US$1.10 billion and EPS of US$0.95 in Q4 2025, before landing at Q2 2026 levels. This sets up a quarter in which investors are likely to focus on how current margins compare with a mixed earnings and revenue path. See our full...
NYSE:UNH
NYSE:UNHHealthcare

Is It Time To Reassess UnitedHealth Group (UNH) After Its Recent 30% Share Price Jump?

If you are wondering whether UnitedHealth Group at around US$367 per share is offering fair value or a possible mispricing, it helps to break the story into what the stock has done recently and what the fundamentals suggest. Over the past month, the stock has returned 30.5%, even though the 1 year return sits at a 3.4% loss and the 3 year return at a 20.5% loss, while the year to date return is 9.2%. Recent coverage has focused on how investors are reassessing large healthcare stocks like...